Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, 2015 to 2022 Growing prevalence of various types of cancer such as carcinoma, sarcoma, etc. and increasing awareness regarding the drawback of chemotherapy are few factors which are expected to boost NDDS in cancer therapy market. Additionally, growing demand for ART for the patients suffering from HIV/AIDS, changing lifestyles such as high tobacco and alcohol consumption and rising demand for novel drug delivery systems such as transdermal patches are the high impact rendering drivers for the growth of this market. Furthermore, rising awareness among healthcare professionals regarding benefits associated with nanoparticles & embrolic agents and technological advancement such as incorporation of nanotechnology in drug delivery system, vaccine drug delivery system & prodrugs for targeted drug delivery are few factors expected to positively reinforce NDDS in cancer therapy market over the forecast period. For More Information on "Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Research Reports" visit - http://www.grandviewresearch.com/industry-analysis/novel-drug-deliverysystems-in-cancer-therapy On the basis of technologies the market is segmented into liquid embrolic, nanoparticles and embolization particles. In 2014, Nanoparticles was one of the highest revenue generating technological segment. Key factors attributing to its large share include growing demand for protecting the drugs from being damaged before reaching the specified area, easy diagnosis by the oncologist to observe how well they are working and preventing the drug interaction with the normal cells or tissues. Nanoparticles used for cancer therapy include DepoCyt (liposomal cytarabine), Megace ES (megestrol acetate), Abraxane (paclitaxel), Doxil (doxorubicin), Myocet (doxorubicin) and DaunoXome (daunorubicin citrate). Embolization particles are further segmented into PVA particles, microspheres, drug eluting beds (DEB), microspheres, radioembolization microspheres/selective internal radiation therapy (SIRT). Key regional markets included in the study are North America, Europe, Asia Pacific, MEA and Latin America. In 2014, North America accounted for significant market share in terms of revenue owing to the factors such as rising incidences of cancer, growing awareness regarding upcoming technologies and treatment options such as target drug delivery, nanoparticles and rising government investment in this sector. However, Asia pacific region is anticipated to witness significant growth over the forecast period. Key factors attributing to its rapid growth include economic development in countries such as Japan, China, India, New Zealand and Australia, favorable government initiatives pertaining to the development of healthcare infrastructure and constantly improving reimbursement policies. Key players operating in NDDS in cancer therapy market include Advanced Medical Isotope Corporation, Boston Scientific Corporation, Bind Therapeutics, Cook Medical Inc., CeloNova BioSciences Inc., BTG plc, Covidien plc, Cospheric LLC, Merit Medical Systems, Inc., EmboMedics Inc., Eckert & Ziegler BEBIG, Kobo Products, Inc., Polysciences Inc., Nanobiotix, Mo-Sci Corporation and Sirtex Medical Limited. Request TOC of “Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Research Reports" visit http://www.grandviewresearch.com/industry-analysis/novel-drug-deliverysystems-in-cancer-therapy/request-toc About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. - Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Website: Grand View Research Blog Site: http://www.divog.org/